Ottawa-based cannabis investment firm CannaRoyalty Corp. (CSE:CRZ) says it’s acquiring a 20 per cent stake in Anandia Laboratories Inc., a company that specializes in marijuana testing, in a deal valued at $4 million.
There are currently seven licensed cannabis producers in Canada who are working with the Vancouver-based cannabis biotechnology company to test their products.
A report released last month by the federally appointed task force on marijuana highlighted the importance of testing cannabis products to ensure they’re safe for consumption.
(Sponsored)
OCOBIA eyes Ottawa BIA expansion as it gears up for election year
Michelle Groulx says it’s not difficult to spot the Ottawa neighbourhoods with their own business improvement area (BIA). That’s because, she says, BIAs are a visual and experiential representation of
Uniting for heart health: A community movement reignites this February
February is Heart Month is here! The Ottawa Heart Institute Foundation has not skipped a beat in preparing for this highly anticipated opportunity for individuals, groups, and businesses to raise
In addition to testing, Anandia Labs also develops cannabis strains for medical use.
The deal, which will be funded through a combination of cash, equipment and services and common shares, is expected to close by Jan. 31, subject to approvals.
CannaRoyalty, or Cannabis Royalties, finances and invests in marijuana companies in Canada and in American states that have legalized the substance.
CEO Mark Lustig told OBJ last month that many cannabis entrepreneurs in North America have great ideas, but are inexperienced in raising capital.
He also sees banks avoiding the risks of the industry, unwilling to dive into the market until they’re sure the majority of investment conditions and risk calculations fall in their favour.
This has created an opening for CannaRoyalty, which is financing and acquiring equity in promising companies in return for ownership, royalties or licensing agreements.
